- Home
- WASH vs PRAX Comparison
WASH vs PRAX Comparison
Compare WASH & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- PRAX
- Stock Information
- Founded
- WASH 1800
- PRAX 2015
- Country
- WASH United States
- PRAX United States
- Employees
- WASH N/A
- PRAX N/A
- Industry
- WASH Major Banks
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- PRAX Health Care
- Exchange
- WASH Nasdaq
- PRAX Nasdaq
- Market Cap
- WASH 567.9M
- PRAX 599.7M
- IPO Year
- WASH N/A
- PRAX 2020
- Fundamental
- Price
- WASH $27.66
- PRAX $38.55
- Analyst Decision
- WASH Buy
- PRAX Strong Buy
- Analyst Count
- WASH 4
- PRAX 10
- Target Price
- WASH $32.25
- PRAX $116.50
- AVG Volume (30 Days)
- WASH 117.9K
- PRAX 320.6K
- Earning Date
- WASH 07-21-2025
- PRAX 05-02-2025
- Dividend Yield
- WASH 8.10%
- PRAX N/A
- EPS Growth
- WASH N/A
- PRAX N/A
- EPS
- WASH N/A
- PRAX N/A
- Revenue
- WASH $110,088,000.00
- PRAX $8,122,000.00
- Revenue This Year
- WASH $57.46
- PRAX N/A
- Revenue Next Year
- WASH $9.82
- PRAX N/A
- P/E Ratio
- WASH N/A
- PRAX N/A
- Revenue Growth
- WASH N/A
- PRAX 270.02
- 52 Week Low
- WASH $24.70
- PRAX $26.70
- 52 Week High
- WASH $40.59
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- WASH 42.62
- PRAX 53.72
- Support Level
- WASH $27.53
- PRAX $35.21
- Resistance Level
- WASH $28.62
- PRAX $38.90
- Average True Range (ATR)
- WASH 0.59
- PRAX 2.09
- MACD
- WASH -0.14
- PRAX 0.07
- Stochastic Oscillator
- WASH 9.70
- PRAX 69.58
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.